pCMV-HA-PD-L1 Citations (1)

Originally described in: Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity.
Li CW, Lim SO, Xia W, Lee HH, Chan LC, Kuo CW, Khoo KH, Chang SS, Cha JH, Kim T, Hsu JL, Wu Y, Hsu JM, Yamaguchi H, Ding Q, Wang Y, Yao J, Lee CC, Wu HJ, Sahin AA, Allison JP, Yu D, Hortobagyi GN, Hung MC Nat Commun. 2016 Aug 30;7:12632. doi: 10.1038/ncomms12632. PubMed Journal

---

Articles Citing pCMV-HA-PD-L1

Articles
Itaconate transporter SLC13A3 confers immunotherapy resistance via alkylation-mediated stabilization of PD-L1. Fan Y, Dan W, Wang Y, Ma Z, Jian Y, Liu T, Li M, Wang Z, Wei Y, Liu B, Ding P, Lei Y, Guo C, Zeng J, Yan X, Wei W, Li L. Cell Metab. 2025 Feb 4;37(2):514-526.e5. doi: 10.1016/j.cmet.2024.11.012. Epub 2025 Jan 13. PubMed

If you have published an article using this material, please email us at to have your article added to this page.